Holen Sie sich die Stockscreener-App
0.5993
15.76%
-0.1121
Prokidney Corp Aktie (PROK) Neueste Nachrichten
Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance
Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance
PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India
ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView
ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty - TipRanks
ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus.com
ProKidney reports larger loss in 2024 as production resumes - Winston-Salem Journal
PROKIDNEY CORP. SEC 10-K Report - TradingView
ProKidney CEO cites 'significant progress' after regenerative medicine company loses $163M in 2024 - The Business Journals
ProKidney reports FY24 EPS (62c), consensus (59c) - TipRanks
ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease - Nasdaq
ProKidney Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewswire
FDA Fast-Tracks ProKidney's CKD Treatment: $358M War Chest Fuels Breakthrough Development - StockTitan
Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
ProKidney (PROK) Expected to Announce Quarterly Earnings on Thursday - Defense World
ProKidney (NASDAQ:PROK) Stock Price Down 2.7%Here's What Happened - MarketBeat
ProKidney stock hits 52-week low at $1.34 amid market challenges - Investing.com Australia
ProKidney stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Review: ProKidney (NASDAQ:PROK) and Adaptimmune Therapeutics (NASDAQ:ADAP) - Defense World
Owning 32% shares,institutional owners seem interested in ProKidney Corp. (NASDAQ:PROK), - Yahoo
ProKidney Corp (NASDAQ: PROK) Has Great Upside Potential - Stocks Register
ProKidney Corp [PROK] Chief Regulatory Officer makes an insider sale of 16,412 shares worth 41,030. - Knox Daily
JPMorgan Chase & Co. Purchases 18,472 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm - The Malaysian Reserve
2025 Will Be A Major Year For ProKidney’s Rilparencel In CKD Treatment (NASDAQ:PROK) - Seeking Alpha
US Penny Stocks: 3 Picks With Market Caps Under $300M - Simply Wall St
ProKidney secures out-of-market buyer, $20.5 million price tag for Greensboro site - The Business Journals
ProKidney's high-profile Greensboro plant initiative ends with planned $20 million sale of property - Winston-Salem Journal
ProKidney (NASDAQ:PROK) Trading 8.7% HigherStill a Buy? - MarketBeat
Insiders In ProKidney Still Down 26% On US$54.7m Investment - Simply Wall St
Barclays PLC Has $281,000 Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
568,647 Shares in ProKidney Corp. (NASDAQ:PROK) Purchased by Hennion & Walsh Asset Management Inc. - MarketBeat
Jane Street Group LLC Has $78,000 Stock Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney Corp (PROK) Analyst Thoughts: How High Can It Go? - Stocks Register
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
ProKidney to Present at J.P. Morgan Healthcare Conference, Spotlight on CKD Cell Therapy - StockTitan
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Geode Capital Management LLC Raises Stake in ProKidney Corp. (NASDAQ:PROK) - MarketBeat
Barclays PLC Purchases 124,667 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
One ProKidney Insider Raised Their Stake In The Previous Year - Yahoo Finance
Stories to Watch in 2025: Will ProKidney change its Winston-Salem plans after abandoning $458M Greensboro facility? - The Business Journals
Cortexyme (NASDAQ:CRTX) vs. ProKidney (NASDAQ:PROK) Head to Head Comparison - Defense World
State Street Corp Has $2.74 Million Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (NASDAQ:PROK) Shares Gap UpStill a Buy? - MarketBeat
TBJ's Top 24 of '24: ProKidney backs out of Guilford deal, invests in W-S facilities (No. 4) - Triad Business Journal
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):